Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Inventory: 2023-2025

Historic Change in Inventory for Krystal Biotech (KRYS) over the last 3 years, with Sep 2025 value amounting to $4.7 million.

  • Krystal Biotech's Change in Inventory rose 28.14% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 99.88%. This contributed to the annual value of $11.9 million for FY2024, which is 166.08% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Change in Inventory is $4.7 million, which was up 635.57% from -$880,000 recorded in Q2 2025.
  • Krystal Biotech's 5-year Change in Inventory high stood at $6.5 million for Q4 2024, and its period low was -$880,000 during Q2 2025.
  • For the 3-year period, Krystal Biotech's Change in Inventory averaged around $2.2 million, with its median value being $1.8 million (2024).
  • Examining YoY changes over the last 5 years, Krystal Biotech's Change in Inventory showed a top increase of 1,225.41% in 2024 and a maximum decrease of 158.50% in 2024.
  • Quarterly analysis of 3 years shows Krystal Biotech's Change in Inventory stood at $492,000 in 2023, then surged by 1,225.41% to $6.5 million in 2024, then rose by 28.14% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, -$880,000 for Q2 2025, and $1.4 million during Q1 2025.